Artificial Intelligence (AI) in Healthcare: Strategic Intelligence
Powered by ![]()
All the vital news, analysis, and commentary curated by our industry experts.
Artificial intelligence (AI) is transforming healthcare through automation, analytics, and the development of smarter clinical tools. Across healthcare providers, pharmaceuticals, and medical devices, the combined AI market was valued at $11.9 billion in 2024 and is expected to reach $57.4 billion by 2029, representing a compound annual growth rate (CAGR) of about 37%.
AI consulting and support services are driving healthcare’s administrative automation and clinical decision support. AI hardware, including robotics and imaging systems, underpins advances in the medical device sector, while AI platforms and specialized applications are reshaping pharmaceutical research and development (R&D). Collectively, these technologies are moving AI from pilots to scaled commercial adoption.
How Healthcare Leaders Are Using This Intelligence
Healthcare decision-makers are leveraging this report to:
-
Prioritize AI investments with confidence: Identify the AI applications delivering the strongest ROI across care delivery, diagnostics, and life sciences, and avoid overhyped or premature use cases.
-
Shape AI adoption and scaling strategies: Move beyond pilots by understanding where AI is already being commercialized and how leading organizations are integrating it into core workflows.
-
Guide product and platform development: Align AI-enabled products and services with real clinical and operational needs, regulatory readiness, and buyer expectations.
-
Strengthen partnerships and ecosystem plays: Benchmark technology vendors, platform providers, and collaborators to build resilient AI ecosystems across healthcare value chains.
-
Future-proof healthcare strategy: Anticipate regulatory, technological, and competitive shifts to ensure AI strategies remain compliant, scalable, and sustainable through 2029 and beyond.
Scope
Accelerating AI adoption across healthcare: AI deployment is expanding rapidly among providers, pharmaceutical companies, and medical technology manufacturers, driven by workforce shortages, rising costs, and a demand for better outcomes.
Transforming drug discovery and development: AI is streamlining target identification, molecule design, clinical trial optimization, and real-world evidence generation, significantly improving R&D productivity.
Regulatory momentum unlocking AI imaging: Clearer regulatory pathways and growing approvals are accelerating the adoption of AI-powered imaging and diagnostic tools, particularly in radiology and pathology.
Who Should Buy This Report
This report is essential for every senior leader and teams shaping the future of healthcare delivery, innovation, and investment, including:
- Healthcare Providers & Hospital Systems
- Pharmaceutical & Biotechnology Companies
- Medical Device & Diagnostics Manufacturers
- Health Tech & AI Solution Providers
- Investors, Consultants & Policymakers
Reasons to Buy
Understand where AI is delivering real value in healthcare: Gain a clear view of how AI is being applied across clinical, operational, and R&D functions and where adoption is scaling fastest.
Benchmark leading players and technologies: Identify the companies shaping the AI in healthcare ecosystem and understand how incumbents and innovators are positioning for long-term growth.
Anticipate the future of AI-driven healthcare: Access forward-looking insights into technology, regulatory, and investment trends to inform strategic planning, partnerships, and product development.
Bristol Myers Squibb
Johnson & Johnson
Lilly
Novartis
Pfizer
Roche
Sanofi
GE Healthcare
Illumina
Medtronic
Phillips
Siemens Healthineers
Table of Contents
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Related reports
View more Medical Devices reports